| _version_ |
1827331164676816896
|
| collection |
DOAJ
|
| first_indexed |
2024-03-07T16:31:10Z
|
| format |
Article
|
| id |
doaj.art-0475c097a3044ac8b85379d7cb898798
|
| institution |
Directory Open Access Journal
|
| issn |
2572-9241
|
| language |
English
|
| last_indexed |
2024-03-07T16:31:10Z
|
| publishDate |
2023-03-01
|
| publisher |
Wiley
|
| record_format |
Article
|
| series |
HemaSphere
|
| spelling |
doaj.art-0475c097a3044ac8b85379d7cb8987982024-03-03T10:39:05ZengWileyHemaSphere2572-92412023-03-0173e85610.1097/HS9.0000000000000856202303000-00010Correction Notice: Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myelomahttp://journals.lww.com/10.1097/HS9.0000000000000856
|
| spellingShingle |
Correction Notice: Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma
HemaSphere
|
| title |
Correction Notice: Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma
|
| title_full |
Correction Notice: Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma
|
| title_fullStr |
Correction Notice: Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma
|
| title_full_unstemmed |
Correction Notice: Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma
|
| title_short |
Correction Notice: Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma
|
| title_sort |
correction notice carfilzomib pomalidomide and dexamethasone as second line therapy for lenalidomide refractory multiple myeloma
|
| url |
http://journals.lww.com/10.1097/HS9.0000000000000856
|